Company · CIK 0000907654 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Oruka Therapeutics, Inc. · ORKA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 SForm 4 → | Sep 21, 5:38 pm EDT | Arjun AgarwalSenior Vice President, Finance | 533 | $95.75 | $51,035 | 14,219 | −3.61% | 10b5-1 |
| Sep 21, 2026 SForm 4 → | Sep 21, 4:57 pm EDT | Paul T QuinlanGeneral Counsel | 10,000 | $93.64 | $936,417 | 29,995 | −25.0% | 10b5-1 |
| Sep 21, 2026 MForm 4 → | Sep 21, 4:57 pm EDT | Paul T QuinlanGeneral Counsel | 10,000 | $7.80 | $78,000 | 39,995 | — | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:18 pm EDT | Joana GoncalvesChief Medical Officer | 7,947 | $92.38 | $734,145 | 31,771 | −20.0% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 15, 7:18 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | $7.32 | $51,240 | 39,718 | — | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:15 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 2,452 | $95.71 | $234,681 | 923,128 | −0.26% | |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:14 pm EDT | Paul T QuinlanGeneral Counsel | 1,039 | $95.71 | $99,443 | 29,995 | −3.35% | |
| Sep 15, 2026 SForm 4 → | Sep 15, 7:11 pm EDT | Laura Lee SandlerChief Operating Officer | 906 | $95.71 | $86,713 | 235,478 | −0.38% | |
| Sep 11, 2026 SForm 4 → | Sep 15, 7:17 pm EDT | Arjun AgarwalSenior Vice President, Finance | 10,019 | $92.43 | $926,010 | 14,752 | −40.4% | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 15, 7:17 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,459 | $15.88 | $150,175 | 24,771 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 6:36 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | $91.82 | $459,101 | 236,384 | −2.07% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 6:36 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | $7.80 | $39,000 | 241,384 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 6:35 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 75,000 | $91.83 | $6,887,484 | 925,580 | −7.50% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 6:35 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 75,000 | $7.80 | $585,000 | 1,000,580 | — | 10b5-1 |
| Aug 24, 2026 AForm 4 → | Aug 25, 4:25 pm EDT | Larry Todd EdwardsChief Commercial Officer | 100,000 | — | — | 100,000 | — | |
| Aug 17, 2026 SForm 4 → | Aug 17, 6:09 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | $111.84 | $782,882 | 32,718 | −17.6% | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 17, 6:09 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | $7.32 | $51,240 | 39,718 | — | 10b5-1 |
| Aug 14, 2026 SForm 4 → | Aug 14, 5:52 pm EDT | Paul T QuinlanGeneral Counsel | 52,000 | $108.49 | $5,641,409 | 31,034 | −62.6% | 10b5-1 |
| Aug 14, 2026 MForm 4 → | Aug 14, 5:52 pm EDT | Paul T QuinlanGeneral Counsel | 52,000 | $11.60 | $603,000 | 83,034 | — | 10b5-1 |
| Aug 13, 2026 SForm 4 → | Aug 14, 5:42 pm EDT | Arjun AgarwalSenior Vice President, Finance | 10,000 | $106.66 | $1,066,572 | 15,312 | −39.5% | 10b5-1 |
| Aug 13, 2026 MForm 4 → | Aug 14, 5:42 pm EDT | Arjun AgarwalSenior Vice President, Finance | 10,000 | $15.69 | $156,916 | 25,312 | — | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 15, 7:36 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | $86.28 | $603,938 | 32,718 | −17.6% | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 15, 7:36 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | $7.32 | $51,240 | 39,718 | — | 10b5-1 |
| Jul 13, 2026 SForm 4 → | Jul 13, 5:09 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,999 | $84.63 | $846,180 | 15,312 | −39.5% | 10b5-1 |
| Jul 13, 2026 MForm 4 → | Jul 13, 5:09 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,999 | $15.69 | $156,903 | 25,311 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 1, 9:30 pm EDT | Fairmount Funds Management LLC +4Director, 10% Owner | 3,553,410 | $84.43 | $300,014,406 | 1,131,954 | −75.8% | |
| Jul 1, 2026 CForm 4 → | Jul 1, 9:30 pm EDT | Fairmount Funds Management LLC +4Director, 10% Owner | 3,553,410 | — | — | 4,685,364 | — | |
| Jul 1, 2026 SForm 4 → | Jul 1, 7:58 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | $94.42 | $472,079 | 236,384 | −2.07% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 1, 7:58 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | $7.80 | $39,000 | 241,384 | — | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 22, 7:59 pm EDT | Arjun AgarwalSenior Vice President, Finance | 1,587 | $80.95 | $128,468 | 15,312 | −9.39% | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 15, 6:54 pm EDT | Joana GoncalvesChief Medical Officer | 7,947 | $69.28 | $550,607 | 32,718 | −19.5% | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 15, 6:54 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | $7.32 | $51,240 | 40,665 | — | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 15, 6:52 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 1,729 | $69.69 | $120,494 | 925,580 | −0.19% | |
| Jun 15, 2026 SForm 4 → | Jun 15, 6:51 pm EDT | Laura Lee SandlerChief Operating Officer | 600 | $69.69 | $41,814 | 236,384 | −0.25% | |
| Jun 15, 2026 SForm 4 → | Jun 15, 6:50 pm EDT | Paul T QuinlanGeneral Counsel | 733 | $69.69 | $51,083 | 31,034 | −2.31% | |
| Jun 12, 2026 SForm 4 → | Jun 15, 6:57 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,854 | $69.72 | $687,035 | 16,899 | −36.8% | 10b5-1 |
| Jun 12, 2026 MForm 4 → | Jun 15, 6:57 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,459 | $15.88 | $150,175 | 26,753 | — | 10b5-1 |
| Jun 11, 2026 SForm 4 → | Jun 12, 4:36 pm EDT | Carl DambkowskiDirector | 35,000 | $70.13 | $2,454,382 | 38,743 | −47.5% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 MForm 4 → | Sep 21, 4:57 pm EDT | Paul T QuinlanGeneral Counsel | 10,000 | — | — | 79,996 | — | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 15, 7:18 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | — | — | 164,992 | — | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 15, 7:17 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,459 | — | — | 58,333 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 6:36 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | — | — | 74,996 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 1, 6:35 pm EDT | Lawrence Otto KleinChief Executive Officer, Director | 75,000 | — | — | 1,553,513 | — | 10b5-1 |
| Aug 24, 2026 AForm 4 → | Aug 25, 4:25 pm EDT | Larry Todd EdwardsChief Commercial Officer | 20,000 | — | — | 20,000 | — | |
| Aug 17, 2026 MForm 4 → | Aug 17, 6:09 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | — | — | 168,492 | — | 10b5-1 |
| Aug 14, 2026 MForm 4 → | Aug 14, 5:52 pm EDT | Paul T QuinlanGeneral Counsel | 52,000 | — | — | 120,500 | — | 10b5-1 |
| Aug 13, 2026 MForm 4 → | Aug 14, 5:42 pm EDT | Arjun AgarwalSenior Vice President, Finance | 10,000 | — | — | 59,792 | — | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 15, 7:36 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | — | — | 171,992 | — | 10b5-1 |
| Jul 13, 2026 MForm 4 → | Jul 13, 5:09 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,999 | — | — | 61,250 | — | 10b5-1 |
| Jul 1, 2026 CForm 4 → | Jul 1, 9:30 pm EDT | Fairmount Funds Management LLC +4Director, 10% Owner | 42,641 | — | — | 94,497 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 7:58 pm EDT | Laura Lee SandlerChief Operating Officer | 5,000 | — | — | 79,996 | — | 10b5-1 |
| Jun 15, 2026 MForm 4 → | Jun 15, 6:54 pm EDT | Joana GoncalvesChief Medical Officer | 7,000 | — | — | 175,492 | — | 10b5-1 |
| Jun 12, 2026 MForm 4 → | Jun 15, 6:57 pm EDT | Arjun AgarwalSenior Vice President, Finance | 9,459 | — | — | 62,708 | — | 10b5-1 |
| Jun 2, 2026 AForm 4 → | Jun 3, 4:52 pm EDT | Carl DambkowskiDirector | 9,136 | — | — | 9,136 | — | |
| Jun 2, 2026 AForm 4 → | Jun 3, 4:50 pm EDT | Samarth KulkarniDirector | 9,136 | — | — | 9,136 | — | |
| Jun 2, 2026 AForm 4 → | Jun 3, 4:49 pm EDT | Christopher Nathan MartinDirector | 9,136 | — | — | 9,136 | — | |
| Jun 2, 2026 AForm 4 → | Jun 3, 4:48 pm EDT | Kristine M BallDirector | 9,136 | — | — | 9,136 | — | |
| Jun 2, 2026 AForm 4 → | Jun 3, 4:45 pm EDT | Fairmount Funds Management LLC +4Director, 10% Owner | 9,136 | — | — | 9,136 | — |